Sales incentives worth ₹165.74 crore released to four pharma companies under PLI scheme

[ad_1] Four pharmaceutical companies have received the first tranche of incentives of up to ₹165.74 crore under the Product Linked Incentive (PLI) scheme of the Department for Pharmaceuticals. The scheme was floated to boost indigenous production of active pharmaceutical ingredients which are the key raw materials in manufacturing drugs.  The firms are Dr. Reddy’s Laboratories Limited, […]

Continue Reading

SEBI warns Aurobindo Pharma over U.S. FDA audit disclosure

[ad_1] Firm disclosed “very limited and restricted information” to stock exchanges about an U.S. FDA plant audit Firm disclosed “very limited and restricted information” to stock exchanges about an U.S. FDA plant audit The Securities and Exchange Board of India (SEBI) has issued a warning letter to Aurobindo Pharma for disclosing “very limited and restricted […]

Continue Reading